In addition, several recent studies indicated that FAK could trigger immune-mediated tumor regression and modulate the immunosuppressive components of the tumor microenvironment; it also has a functional association with immune checkpoints, and regulates sensitivity to immunotherapy [48,49,50,51,52]. This evidence concerns the gene PTK2 and neoplasm.